Clinical outcomes of cyclin-dependent kinase 4-6 (CDK 4-6) inhibitors in patients with male breast cancer: A multicenter study

Yildirim, HC; Mutlu, E; Chalabiyev, E; Ozen, M; Keskinkilic, M; On, S; Celebi, A; Dursun, B; Acar, O; Kahraman, S; Aykan, MB; Kaman, O; Dogan, A; Erdogan, AP; Celayir, OM; Gunenc, D; Guven, DC; Bayoglu, IV; Yavuzsen, T; Hacibekiroglu, I; Inanc, M; Kilickap, S; Yalcin, S; Aksoy, S

Yildirim, HC (通讯作者)，Hacettepe Univ, Tip Fak, Tibbi Onkol Bilim Dali Hacettepe, Mehmet Akif Ersoy Sk 19, TR-06230 Ankara, Turkey.

BREAST, 2022; 66 (): 85

Abstract

Background: Since breast cancer is less common in men than in women, data on the use of new therapeutic agents, including cyclin-dependent kinase 4-6 ......

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索